Aptorum Group Revenue 2018-2020 | APM

Aptorum Group revenue from 2018 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Aptorum Group Annual Revenue
(Millions of US $)
2019 $1
2018 $0
2017 $
Aptorum Group Quarterly Revenue
(Millions of US $)
2020-06-30
2019-12-31
2019-06-30
2018-12-31
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.049B $0.001B
Aptorum Group Limited is a pharmaceutical company. It engaged in developing and commercializing therapeutic and diagnostic technologies to tackle unmet medical needs. The company's therapeutic and diagnostic project primarily includes neurology, infectious diseases, gastroenterology, oncology and other disease areas. Aptorum Group Limited is based in Connaught Road, Hong Kong.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.437B 43.48
Takeda Pharmaceutical (TAK) Japan $58.988B 10.28
Astellas Pharma (ALPMY) Japan $28.765B 14.58
Eisai (ESALY) Japan $26.988B 22.81
UCB SA (UCBJF) Belgium $22.446B 0.00
Merck (MKGAF) Germany $19.393B 25.43
Ono Pharmaceutical (OPHLF) Japan $15.737B 27.83
Catalent (CTLT) United States $13.930B 45.39
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Grifols, S.A (GRFS) Spain $11.111B 13.58
Neurocrine Biosciences (NBIX) United States $9.479B 36.70
IPSEN SA ADR (IPSEY) France $9.085B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.360B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.870B 13.02
Ionis Pharmaceuticals (IONS) United States $7.179B 45.48
Orion OYJ (ORINY) Finland $7.077B 24.56
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
United Therapeutics (UTHR) United States $4.694B 10.85
Arrowhead Pharmaceuticals (ARWR) United States $4.409B 0.00
FibroGen (FGEN) United States $4.022B 0.00
Evotec AG (EVTCY) Germany $4.014B 139.34
ChemoCentryx (CCXI) United States $3.810B 0.00
Nektar Therapeutics (NKTR) United States $3.608B 0.00
Hypermarcas (HYPMY) Brazil $3.528B 12.98
Sage Therapeutics (SAGE) United States $3.246B 0.00
PTC Therapeutics (PTCT) United States $3.197B 0.00
Pacira BioSciences (PCRX) United States $2.597B 68.28
Xencor (XNCR) United States $2.463B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.219B 10.74
Corcept Therapeutics (CORT) United States $2.079B 19.14
Revolution Medicines (RVMD) United States $2.040B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.963B 0.00
Cronos Group (CRON) Canada $1.851B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.600B 11.11
USANA Health Sciences (USNA) United States $1.584B 14.92
Heron Therapeutics (HRTX) United States $1.479B 0.00
Trillium Therapeutics (TRIL) Canada $1.353B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.342B 12.80
Zogenix (ZGNX) United States $1.342B 0.00
Karyopharm Therapeutics (KPTI) United States $1.199B 0.00
Indivior (INVVY) United States $1.163B 14.42
Theravance Biopharma (TBPH) Cayman Islands $1.140B 0.00
Translate Bio (TBIO) United States $1.097B 0.00
Esperion Therapeutics (ESPR) United States $1.091B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.991B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.927B 577.00
VAXART, INC (VXRT) United States $0.898B 0.00
Vectura Group (VEGPF) United Kingdom $0.894B 0.00
Endo (ENDP) Ireland $0.749B 1.11
Spectrum Pharmaceuticals (SPPI) United States $0.714B 0.00
ImmunoGen (IMGN) United States $0.710B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.708B 0.00
Collegium Pharmaceutical (COLL) United States $0.698B 0.00
Tilray (TLRY) Canada $0.679B 0.00
Molecular Templates (MTEM) United States $0.615B 0.00
Flexion Therapeutics (FLXN) United States $0.591B 0.00
Siga Technologies (SIGA) United States $0.583B 62.17
Ocular Therapeutix (OCUL) United States $0.582B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.570B 0.00
Aerie Pharmaceuticals (AERI) United States $0.567B 0.00
Radius Health (RDUS) United States $0.560B 0.00
Ardelyx (ARDX) United States $0.540B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.519B 0.00
Harpoon Therapeutics (HARP) United States $0.466B 0.00
Altimmune (ALT) United States $0.465B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.429B 0.00
Organogenesis Holdings (ORGO) United States $0.428B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.417B 20.80
Akebia Therapeutics (AKBA) United States $0.401B 0.00
MEI Pharma (MEIP) United States $0.398B 0.00
TherapeuticsMD (TXMD) United States $0.395B 0.00
Redhill Biopharma (RDHL) Israel $0.372B 0.00
DURECT (DRRX) United States $0.371B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.348B 8.62
Jounce Therapeutics (JNCE) United States $0.336B 15.89
IMV INC (IMV) Canada $0.332B 0.00
PROFOUND MEDICL (PROF) Canada $0.329B 0.00
Innate Pharma SA (IPHYF) France $0.324B 0.00
Concert Pharmaceuticals (CNCE) United States $0.316B 0.00
Aquestive Therapeutics (AQST) United States $0.304B 0.00
Xeris Pharmaceuticals (XERS) United States $0.293B 0.00
Rafael Holdings (RFL) United States $0.280B 0.00
Calithera Biosciences (CALA) United States $0.270B 0.00
Lannett Co Inc (LCI) United States $0.257B 5.96
KalVista Pharmaceuticals (KALV) United States $0.247B 0.00
Nature's Sunshine Products (NATR) United States $0.246B 24.25
Oasmia Pharmaceutical AB (OASMY) Sweden $0.229B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.220B 0.00
Heat Biologics (HTBX) United States $0.209B 0.00
Nivalis Therapeutics (ALPN) United States $0.206B 0.00
CASI Pharmaceuticals (CASI) United States $0.201B 0.00
OptiNose (OPTN) United States $0.199B 0.00
Otonomy (OTIC) United States $0.191B 0.00
Taiwan Liposome (TLC) Taiwan $0.165B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.160B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.155B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.142B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.140B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.129B 0.00
Champions Oncology (CSBR) United States $0.116B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.108B 0.00
Aclaris Therapeutics (ACRS) United States $0.108B 0.00
Lipocine (LPCN) United States $0.106B 0.00
MediWound (MDWD) Israel $0.100B 0.00
Biomerica (BMRA) United States $0.089B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.084B 0.00
CTI BioPharma (CTIC) United States $0.083B 0.00
Hemispherx BioPharma (AIM) United States $0.083B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.080B 0.00
ElectroCore (ECOR) United States $0.079B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.078B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.075B 0.00
Novan (NOVN) United States $0.073B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.067B 0.00
Addex Therapeutics (ADXN) Switzerland $0.067B 0.00
Infinity Pharmaceuticals (INFI) United States $0.065B 0.00
Recro Pharma (REPH) United States $0.059B 0.00
Onconova Therapeutics (ONTX) United States $0.058B 0.00
SCYNEXIS (SCYX) United States $0.057B 0.00
CV Sciences (CVSI) United States $0.053B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.053B 0.00
KemPharm (KMPH) United States $0.051B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 30.27
India Globalization Capital (IGC) United States $0.049B 0.00
Natural Alternatives (NAII) United States $0.046B 0.00
ProPhase Labs (PRPH) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
GTx (ONCT) United States $0.043B 0.00
IsoRay (ISR) United States $0.043B 0.00
PolarityTE (PTE) United States $0.043B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.039B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.038B 0.00
Mannatechorporated (MTEX) United States $0.036B 9.09
AgeX Therapeutics (AGE) United States $0.035B 0.00
Neos Therapeutics (NEOS) United States $0.033B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.030B 0.00
Can-Fite Biopharma (CANF) Israel $0.029B 0.00
Jaguar Animal Health (JAGX) United States $0.029B 0.00
Sundial Growers (SNDL) Canada $0.028B 0.00
Midatech Pharma (MTP) United Kingdom $0.024B 0.00
Vical (BBI) United States $0.023B 0.00
Regulus Therapeutics (RGLS) United States $0.020B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Flex Pharma (SLRX) United States $0.017B 0.00
Bio-Path Holdings (BPTH) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.016B 24.36
Sonoma Pharmaceuticals (SNOA) United States $0.016B 0.00
HANCOCK JAFFE (HJLI) United States $0.015B 0.00
RXi Pharmaceuticals (PHIO) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.014B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.013B 0.00
JanOne (JAN) United States $0.009B 0.00
China SXT Pharmaceuticals (SXTC) China $0.008B 0.00
Shineco (TYHT) China $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00